Standard Glass Lining Technology Ltd
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India.[1]
- Market Cap ₹ 3,388 Cr.
- Current Price ₹ 170
- High / Low ₹ 214 / 124
- Stock P/E 47.6
- Book Value ₹ 37.5
- Dividend Yield 0.00 %
- ROCE 16.5 %
- ROE 11.6 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 99.4 to 127 days.
- Working capital days have increased from 172 days to 272 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE SmallCap BSE IPO BSE Allcap BSE Industrials
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 240 | 498 | 544 | 614 | 662 | |
| 200 | 412 | 449 | 506 | 555 | |
| Operating Profit | 40 | 86 | 95 | 107 | 108 |
| OPM % | 17% | 17% | 17% | 18% | 16% |
| 1 | 2 | 6 | 12 | 18 | |
| Interest | 4 | 9 | 12 | 15 | 12 |
| Depreciation | 4 | 8 | 9 | 11 | 14 |
| Profit before tax | 34 | 72 | 80 | 94 | 100 |
| Tax % | 26% | 26% | 25% | 27% | |
| 25 | 53 | 60 | 69 | 74 | |
| EPS in Rs | 16.44 | 33.84 | 32.14 | 3.23 | 3.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 19% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 15 | 16 | 18 | 199 | 199 |
| Reserves | 54 | 140 | 389 | 507 | 548 |
| 70 | 82 | 129 | 68 | 137 | |
| 159 | 110 | 129 | 184 | 269 | |
| Total Liabilities | 298 | 348 | 665 | 958 | 1,154 |
| 52 | 75 | 96 | 136 | 145 | |
| CWIP | 1 | 3 | 4 | 8 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 245 | 269 | 565 | 814 | 1,000 | |
| Total Assets | 298 | 348 | 665 | 958 | 1,154 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -7 | 2 | -65 | 5 | |
| -30 | -29 | -157 | -160 | |
| 37 | 33 | 232 | 141 | |
| Net Cash Flow | 0 | 5 | 10 | -14 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 125 | 67 | 104 | 127 |
| Inventory Days | 399 | 183 | 258 | 296 |
| Days Payable | 198 | 96 | 102 | 115 |
| Cash Conversion Cycle | 326 | 154 | 260 | 309 |
| Working Capital Days | 53 | 66 | 178 | 272 |
| ROCE % | 43% | 24% | 16% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 1d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Q2 FY26 earnings conference call recording posted; call hosted November 06, 2025.
- Announcement under Regulation 30 (LODR)-Investor Presentation 2d
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
5 Nov - ICRA report: Q2 FY2026 IPO proceeds utilization aligned; issue size INR410.05cr, net proceeds INR193.425cr.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
5 Nov - H1 FY26: Total Income ₹366Cr, PAT ₹42Cr; acquired Scigenics ₹9Cr; signed Nov 3 term-sheet to buy 51% of C2C
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT
Business Overview[1] Standard Glass is among the top 5 specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India (FY24 revenue basis). It provides end-to-end solutions including design, manufacturing, assembly, installation, and commissioning of equipment with over 65+ unique designs and over 11,000 units delivered.